Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
198 studies found for:    "Roussy Levy syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Roussy Levy syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
Condition: Charcot Marie Tooth Disease
Interventions: Drug: Coenzyme Q10;   Dietary Supplement: Coenzyme Q10
2 Recruiting Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Condition: Charcot Marie Tooth Disease
Intervention:
3 Recruiting Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)
Condition: Charcot-Marie-Tooth Disease
Intervention: Other: No intervention involved
4 Recruiting Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Condition: Charcot Marie Tooth Disease
Intervention:
5 Unknown  Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
Conditions: Charcot-Marie-Tooth Disease;   Charcot-Marie-Tooth Disease Type 1A
Interventions: Other: TreSPE;   Other: SPE
6 Completed Nociceptive Processing in Acute Cutaneous Nerve Entrapment Syndrome
Condition: Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
Intervention: Other: Quantitative Sensory Testing analysis
7 Unknown  Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A
Condition: Charcot-Marie-Tooth Type 1A Neuropathy
Intervention:
8 Not yet recruiting Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
Condition: Charcot-Marie-Tooth Disease Type 1A
Interventions: Other: Clinical evaluation;   Other: electrophysiological record;   Other: Muscle MRI;   Other: blood samples analysis
9 Active, not recruiting Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Condition: Charcot Marie Tooth Disease
Interventions: Other: Placebo;   Drug: Mexiletine
10 Recruiting Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
Conditions: Charcot-Marie-Tooth Disease, Type Ia (Disorder);   HMSN
Intervention:
11 Completed Ascorbic Acid Treatment in CMT1A Trial (AATIC)
Conditions: Charcot-Marie-Tooth Disease;   Hereditary Motor and Sensory Neuropathies
Interventions: Drug: Placebo;   Drug: ascorbic acid
12 Recruiting Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
Conditions: Charcot Marie Tooth Disease;   Inherited Peripheral Neuropathy
Intervention:
13 Completed Follow up and Observation of Charcot Marie Tooth Disease in Families
Condition: Charcot-Marie-Tooth Disease
Intervention:
14 Completed Development and Validation of a Disability Severity Index for CMT
Condition: Charcot Marie Tooth Disease
Intervention:
15 Completed Survey of Current Management of Orthopaedic Complications in CMT Patients
Condition: Charcot-Marie-Tooth Disease
Intervention: Other: Survey
16 Completed High Dose Ascorbic Acid Treatment of CMT1A
Condition: Charcot-Marie-Tooth Disease, Type Ia
Interventions: Drug: Ascorbic acid (Vitamin C);   Drug: placebo
17 Completed Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
Conditions: Charcot-Marie-Tooth Disease;   Hereditary Neuropathy With Liability to Pressure Palsies;   Genetic Disorders;   Tooth Disorders
Interventions: Drug: PXT3003;   Other: Placebo
18 Completed Study Evaluating Treatment of Forefoot Pain Related to Nerve Entrapment Using the Cryo-Touch III Device
Condition: Entrapment Neuropathy
Intervention: Device: Cryo-Touch III Device
19 Recruiting Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Condition: Charcot-Marie-Tooth Disease Type 1A
Interventions: Drug: PXT3003 dose 1;   Drug: PXT3003 dose 2;   Drug: placebo
20 Completed An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients
Conditions: Charcot Marie Tooth Disease (CMT);   Hereditary Sensory and Motor Neuropathy;   Nerve Compression Syndromes;   Tooth Diseases;   Congenital Abnormalities;   Genetic Diseases, Inborn;   Heredodegenerative Disorders, Nervous System
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.